OrthoPediatrics Corp. (NASDAQ:KIDS) Insider Gregory A. Odle Sells 5,359 Shares

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory A. Odle sold 5,359 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the completion of the sale, the insider now owns 148,788 shares in the company, valued at $3,698,869.68. This represents a 3.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock traded up $0.46 on Tuesday, hitting $25.42. 138,044 shares of the company’s stock were exchanged, compared to its average volume of 162,840. The company has a 50-day simple moving average of $24.74 and a 200-day simple moving average of $25.62. The stock has a market capitalization of $617.38 million, a PE ratio of -20.67 and a beta of 1.22. OrthoPediatrics Corp. has a 1 year low of $21.02 and a 1 year high of $35.99. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter last year, the company posted ($0.23) EPS. As a group, equities analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Institutional Trading of OrthoPediatrics

Institutional investors and hedge funds have recently modified their holdings of the company. Invesco Ltd. increased its holdings in OrthoPediatrics by 3.0% in the 4th quarter. Invesco Ltd. now owns 16,363 shares of the company’s stock valued at $379,000 after acquiring an additional 469 shares during the last quarter. Northern Trust Corp increased its holdings in OrthoPediatrics by 0.3% in the 4th quarter. Northern Trust Corp now owns 193,798 shares of the company’s stock valued at $4,492,000 after acquiring an additional 644 shares during the last quarter. Quarry LP bought a new stake in OrthoPediatrics in the 3rd quarter valued at $25,000. Rhumbline Advisers increased its holdings in OrthoPediatrics by 4.1% in the 4th quarter. Rhumbline Advisers now owns 26,411 shares of the company’s stock valued at $612,000 after acquiring an additional 1,042 shares during the last quarter. Finally, Quantbot Technologies LP increased its holdings in shares of OrthoPediatrics by 42.2% in the 3rd quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Truist Financial dropped their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th. Finally, Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 5th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.